Current approval of medicines is failing to detect the signals of harms within the evidence-base. Problems within the regulatory system have often led to the approval of ineffective and harmful drugs. Postmarketing is largely ineffective in detecting problems once a drug is on the market. New solutions to address these problems are needed, however, finding solutions to better detect, analyse and report harms will not be straightforward. Advance the detection and reporting/safety signals for medicines is critical to providing better healthcare for all.  

This three-day forum focuses on the tasks ahead in order to provide solutions for better detection, analysis and reporting of harms.  

Invited individuals have expertise and/or experience in:

• Pharmacovigilance
• Drug regulation
• the reporting and communicating of medicine harms 

The next generation of problem solvers is also included to contribute to the solutions which will go far into the future.